Industry Research Reports
Home > Reports > Medical Care > Global Biological Indicators Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Biological Indicators Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Medical Care
Published Date: 2025-03-28
Pages: 98 Pages
Report ld: 4682762
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Biological Indicators Market Size(US$)
CAGR 2025-2031
5.9%
Market Size,2031
USD 610
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 433 million
Market Forecast in 2031(Value)
US$ 610 million
CAGR
5.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Biological Indicators market size was US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Biological Indicators (BIs) play a critical role in sterilization validation and infection control, widely used in medical devices, pharmaceuticals, food processing, and life sciences laboratories. They assess the effectiveness of steam, dry heat, ethylene oxide (EO), hydrogen peroxide, and other sterilization methods, ensuring compliance with ISO 11138, USP, and FDA regulations.
Based on form factor, BIs can be categorized into Self-Contained Biological Indicators (SCBIs), BI Strips, and BI Suspensions. Among them, SCBIs are widely used due to their convenience, reduced contamination risk, and enhanced validation efficiency.
In terms of application, the medical sector dominates the market, as hospitals and medical device manufacturers must routinely validate sterilization equipment like autoclaves and plasma sterilizers. The pharmaceutical industry also has stringent requirements for sterilization, especially in injectable drugs, vaccines, and sterile drug production. Additionally, the food and beverage sector is increasingly adopting BIs to monitor sterilization efficiency in processing equipment, ensuring food safety and regulatory compliance.
Regionally, North America is the largest market, with a share nearly 55%. North America and Europe lead the market due to stringent medical regulations and high industry standards. The Asia-Pacific region (especially China and India) is experiencing rapid growth in the BI market, driven by expanding healthcare and pharmaceutical industries and evolving regulatory frameworks. Latin America and the Middle East are also emerging markets, benefiting from improvements in healthcare infrastructure.
Looking ahead, the BI industry is shifting toward more efficient, intelligent, and automated solutions. Rapid-read BIs, electronic BIs (E-BIs), and smart monitoring systems are gradually replacing traditional methods, reducing manual intervention, accelerating sterilization validation, and improving quality control. As pharmaceutical regulations tighten and medical device standards advance, the demand for BIs is expected to rise, ensuring a more reliable approach to sterilization validation and infection control worldwide.
The global Biological Indicators market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- 3M
- Getinge Group
- Cantel Medical
- Mesa Laboratories
- Steris
- Fuze Medical
- Matachana
- Hu-Friedy
- Advanced Sterilization
- Bag Health Care
- Terragene
- Andersen
- GKE
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Self-Contained Biological Indicator
- Biological Indicator Strip
- Others
Segment by Application
- Hospital
- Pharma Companies
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Biological Indicators market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Biological Indicator Strip in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharma Companies in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Biological Indicators value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Self-Contained Biological Indicator
1.2.3 Biological Indicator Strip
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pharma Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Indicators Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Biological Indicators Revenue Market Share by Region (2020-2025)
2.4 Global Biological Indicators Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Biological Indicators Market Size and Prospective (2020-2031)
2.5.2 Europe Biological Indicators Market Size and Prospective (2020-2031)
2.5.3 China Biological Indicators Market Size and Prospective (2020-2031)
2.5.4 South America Biological Indicators Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Biological Indicators Historic Market Size by Type (2020-2025)
3.2 Global Biological Indicators Forecasted Market Size by Type (2026-2031)
3.3 Different Types Biological Indicators Representative Players
4 Breakdown Data by Application
4.1 Global Biological Indicators Historic Market Size by Application (2020-2025)
4.2 Global Biological Indicators Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Biological Indicators Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Biological Indicators Players by Revenue (2020-2025)
5.1.2 Global Biological Indicators Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Biological Indicators Revenue
5.4 Global Biological Indicators Market Concentration Analysis
5.4.1 Global Biological Indicators Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Biological Indicators Revenue in 2024
5.5 Global Key Players of Biological Indicators Head office and Area Served
5.6 Global Key Players of Biological Indicators, Product and Application
5.7 Global Key Players of Biological Indicators, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Biological Indicators Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Biological Indicators Market Size by Type (2020-2025)
6.1.2.2 North America Biological Indicators Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Biological Indicators Market Size by Application (2020-2025)
6.1.3.2 North America Biological Indicators Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Biological Indicators Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Biological Indicators Market Size by Type (2020-2025)
6.2.2.2 Europe Biological Indicators Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Biological Indicators Market Size by Application (2020-2025)
6.2.3.2 Europe Biological Indicators Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Biological Indicators Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Biological Indicators Market Size by Type (2020-2025)
6.3.2.2 China Biological Indicators Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Biological Indicators Market Size by Application (2020-2025)
6.3.3.2 China Biological Indicators Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 South America Market: Players, Segments and Downstream
6.4.1 South America Biological Indicators Revenue by Company (2020-2025)
6.4.2 South America Market Size by Type
6.4.2.1 South America Biological Indicators Market Size by Type (2020-2025)
6.4.2.2 South America Biological Indicators Market Share by Type (2020-2025)
6.4.3 South America Market Size by Application
6.4.3.1 South America Biological Indicators Market Size by Application (2020-2025)
6.4.3.2 South America Biological Indicators Market Share by Application (2020-2025)
6.4.4 South America Market Trend and Opportunities
7 Key Players Profiles
7.1 3M
7.1.1 3M Company Details
7.1.2 3M Business Overview
7.1.3 3M Biological Indicators Introduction
7.1.4 3M Revenue in Biological Indicators Business (2020-2025)
7.1.5 3M Recent Development
7.2 Getinge Group
7.2.1 Getinge Group Company Details
7.2.2 Getinge Group Business Overview
7.2.3 Getinge Group Biological Indicators Introduction
7.2.4 Getinge Group Revenue in Biological Indicators Business (2020-2025)
7.2.5 Getinge Group Recent Development
7.3 Cantel Medical
7.3.1 Cantel Medical Company Details
7.3.2 Cantel Medical Business Overview
7.3.3 Cantel Medical Biological Indicators Introduction
7.3.4 Cantel Medical Revenue in Biological Indicators Business (2020-2025)
7.3.5 Cantel Medical Recent Development
7.4 Mesa Laboratories
7.4.1 Mesa Laboratories Company Details
7.4.2 Mesa Laboratories Business Overview
7.4.3 Mesa Laboratories Biological Indicators Introduction
7.4.4 Mesa Laboratories Revenue in Biological Indicators Business (2020-2025)
7.4.5 Mesa Laboratories Recent Development
7.5 Steris
7.5.1 Steris Company Details
7.5.2 Steris Business Overview
7.5.3 Steris Biological Indicators Introduction
7.5.4 Steris Revenue in Biological Indicators Business (2020-2025)
7.5.5 Steris Recent Development
7.6 Fuze Medical
7.6.1 Fuze Medical Company Details
7.6.2 Fuze Medical Business Overview
7.6.3 Fuze Medical Biological Indicators Introduction
7.6.4 Fuze Medical Revenue in Biological Indicators Business (2020-2025)
7.6.5 Fuze Medical Recent Development
7.7 Matachana
7.7.1 Matachana Company Details
7.7.2 Matachana Business Overview
7.7.3 Matachana Biological Indicators Introduction
7.7.4 Matachana Revenue in Biological Indicators Business (2020-2025)
7.7.5 Matachana Recent Development
7.8 Hu-Friedy
7.8.1 Hu-Friedy Company Details
7.8.2 Hu-Friedy Business Overview
7.8.3 Hu-Friedy Biological Indicators Introduction
7.8.4 Hu-Friedy Revenue in Biological Indicators Business (2020-2025)
7.8.5 Hu-Friedy Recent Development
7.9 Advanced Sterilization
7.9.1 Advanced Sterilization Company Details
7.9.2 Advanced Sterilization Business Overview
7.9.3 Advanced Sterilization Biological Indicators Introduction
7.9.4 Advanced Sterilization Revenue in Biological Indicators Business (2020-2025)
7.9.5 Advanced Sterilization Recent Development
7.10 Bag Health Care
7.10.1 Bag Health Care Company Details
7.10.2 Bag Health Care Business Overview
7.10.3 Bag Health Care Biological Indicators Introduction
7.10.4 Bag Health Care Revenue in Biological Indicators Business (2020-2025)
7.10.5 Bag Health Care Recent Development
7.11 Terragene
7.11.1 Terragene Company Details
7.11.2 Terragene Business Overview
7.11.3 Terragene Biological Indicators Introduction
7.11.4 Terragene Revenue in Biological Indicators Business (2020-2025)
7.11.5 Terragene Recent Development
7.12 Andersen
7.12.1 Andersen Company Details
7.12.2 Andersen Business Overview
7.12.3 Andersen Biological Indicators Introduction
7.12.4 Andersen Revenue in Biological Indicators Business (2020-2025)
7.12.5 Andersen Recent Development
7.13 GKE
7.13.1 GKE Company Details
7.13.2 GKE Business Overview
7.13.3 GKE Biological Indicators Introduction
7.13.4 GKE Revenue in Biological Indicators Business (2020-2025)
7.13.5 GKE Recent Development
8 Biological Indicators Market Dynamics
8.1 Biological Indicators Industry Trends
8.2 Biological Indicators Market Drivers
8.3 Biological Indicators Market Challenges
8.4 Biological Indicators Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Biological Indicators Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Biological Indicators Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Biological Indicators Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Biological Indicators Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Biological Indicators Revenue Share by Region (2020-2025)
Table 6. Global Biological Indicators Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Biological Indicators Revenue Share Forecast by Region (2026-2031)
Table 8. Global Biological Indicators Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Biological Indicators Revenue Market Share by Type (2020-2025)
Table 10. Global Biological Indicators Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Biological Indicators Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Biological Indicators Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Biological Indicators Revenue Market Share by Application (2020-2025)
Table 15. Global Biological Indicators Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Biological Indicators Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Biological Indicators Application
Table 18. Global Biological Indicators Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Biological Indicators Market Share by Players (2020-2025)
Table 20. Global Top Biological Indicators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Indicators as of 2024)
Table 21. Ranking of Global Top Biological Indicators Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Biological Indicators Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Biological Indicators, Headquarters and Area Served
Table 24. Global Key Players of Biological Indicators, Product and Application
Table 25. Global Key Players of Biological Indicators, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Biological Indicators Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Biological Indicators Revenue Market Share by Company (2020-2025)
Table 29. North America Biological Indicators Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Biological Indicators Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Biological Indicators Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Biological Indicators Revenue Market Share by Company (2020-2025)
Table 33. Europe Biological Indicators Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Biological Indicators Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Biological Indicators Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Biological Indicators Revenue Market Share by Company (2020-2025)
Table 37. China Biological Indicators Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Biological Indicators Market Size by Application (2020-2025) & (US$ Million)
Table 39. South America Biological Indicators Revenue by Company (2020-2025) & (US$ Million)
Table 40. South America Biological Indicators Revenue Market Share by Company (2020-2025)
Table 41. South America Biological Indicators Market Size by Type (2020-2025) & (US$ Million)
Table 42. South America Biological Indicators Market Size by Application (2020-2025) & (US$ Million)
Table 43. 3M Company Details
Table 44. 3M Business Overview
Table 45. 3M Biological Indicators Product
Table 46. 3M Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 47. 3M Recent Development
Table 48. Getinge Group Company Details
Table 49. Getinge Group Business Overview
Table 50. Getinge Group Biological Indicators Product
Table 51. Getinge Group Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 52. Getinge Group Recent Development
Table 53. Cantel Medical Company Details
Table 54. Cantel Medical Business Overview
Table 55. Cantel Medical Biological Indicators Product
Table 56. Cantel Medical Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 57. Cantel Medical Recent Development
Table 58. Mesa Laboratories Company Details
Table 59. Mesa Laboratories Business Overview
Table 60. Mesa Laboratories Biological Indicators Product
Table 61. Mesa Laboratories Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 62. Mesa Laboratories Recent Development
Table 63. Steris Company Details
Table 64. Steris Business Overview
Table 65. Steris Biological Indicators Product
Table 66. Steris Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 67. Steris Recent Development
Table 68. Fuze Medical Company Details
Table 69. Fuze Medical Business Overview
Table 70. Fuze Medical Biological Indicators Product
Table 71. Fuze Medical Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 72. Fuze Medical Recent Development
Table 73. Matachana Company Details
Table 74. Matachana Business Overview
Table 75. Matachana Biological Indicators Product
Table 76. Matachana Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 77. Matachana Recent Development
Table 78. Hu-Friedy Company Details
Table 79. Hu-Friedy Business Overview
Table 80. Hu-Friedy Biological Indicators Product
Table 81. Hu-Friedy Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 82. Hu-Friedy Recent Development
Table 83. Advanced Sterilization Company Details
Table 84. Advanced Sterilization Business Overview
Table 85. Advanced Sterilization Biological Indicators Product
Table 86. Advanced Sterilization Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 87. Advanced Sterilization Recent Development
Table 88. Bag Health Care Company Details
Table 89. Bag Health Care Business Overview
Table 90. Bag Health Care Biological Indicators Product
Table 91. Bag Health Care Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 92. Bag Health Care Recent Development
Table 93. Terragene Company Details
Table 94. Terragene Business Overview
Table 95. Terragene Biological Indicators Product
Table 96. Terragene Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 97. Terragene Recent Development
Table 98. Andersen Company Details
Table 99. Andersen Business Overview
Table 100. Andersen Biological Indicators Product
Table 101. Andersen Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 102. Andersen Recent Development
Table 103. GKE Company Details
Table 104. GKE Business Overview
Table 105. GKE Biological Indicators Product
Table 106. GKE Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 107. GKE Recent Development
Table 108. Biological Indicators Market Trends
Table 109. Biological Indicators Market Drivers
Table 110. Biological Indicators Market Challenges
Table 111. Biological Indicators Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Biological Indicators Product Picture
Figure 2. Global Biological Indicators Market Share by Type: 2024 VS 2031
Figure 3. Self-Contained Biological Indicator Features
Figure 4. Biological Indicator Strip Features
Figure 5. Others Features
Figure 6. Global Biological Indicators Market Share by Application: 2024 VS 2031
Figure 7. Hospital
Figure 8. Pharma Companies
Figure 9. Others
Figure 10. Biological Indicators Report Years Considered
Figure 11. Global Biological Indicators Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Biological Indicators Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Biological Indicators Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Biological Indicators Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Biological Indicators Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Biological Indicators Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. South America Biological Indicators Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Biological Indicators Market Share by Players in 2024
Figure 19. Global Top Biological Indicators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Indicators as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Biological Indicators Revenue in 2024
Figure 21. North America Biological Indicators Market Share by Type (2020-2025)
Figure 22. North America Biological Indicators Market Share by Application (2020-2025)
Figure 23. Europe Biological Indicators Market Share by Type (2020-2025)
Figure 24. Europe Biological Indicators Market Share by Application (2020-2025)
Figure 25. China Biological Indicators Market Share by Type (2020-2025)
Figure 26. China Biological Indicators Market Share by Application (2020-2025)
Figure 27. South America Biological Indicators Market Share by Type (2020-2025)
Figure 28. South America Biological Indicators Market Share by Application (2020-2025)
Figure 29. 3M Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 30. Getinge Group Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 31. Cantel Medical Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 32. Mesa Laboratories Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 33. Steris Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 34. Fuze Medical Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 35. Matachana Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 36. Hu-Friedy Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 37. Advanced Sterilization Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 38. Bag Health Care Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 39. Terragene Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 40. Andersen Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 41. GKE Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Biological Indicators in 2031?
The global market size of Biological Indicators in 2031 was 610 Million USD.
What was the global market size of Biological Indicators in 2025?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Biological Indicators market size from 2025 to 2031?
Which companies rank high in the global Biological Indicators market?
Related Reports
Global Biological Indicators Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Biological Indicators market size was US$ 433 million in 2025 and is forecast to reach a readjusted size of US$ 643 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 93
USD 4250.00
(Single User License)
Global Biological Indicators Market Research Report 2026
The global Biological Indicators market was valued at US$ 433 million in 2025 and is anticipated to reach US$ 643 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Biological Indicators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biological Indicators was estimated to be worth US$ 433 million in 2025 and is projected to reach US$ 643 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
Biological Indicators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological Indicators was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-11-03
Pages: 115
USD 3950.00
(Single User License)
Global Biological Indicators Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biological Indicators market is projected to grow from US$ 411 million in 2024 to US$ 610 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 136
USD 4900.00
(Single User License)
Global Biological Indicators Market Insights, Forecast to 2031
The global Biological Indicators market is projected to grow from US$ 433 million in 2025 to US$ 610 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.
Published Date: 2025-03-28
Pages: 143
USD 4900.00
(Single User License)
Global Biological Indicators Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Biological Indicators was estimated to be worth US$ 411 million and is forecast to reach approximately US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 132
USD 5900.00
(Single User License)
Global Biological Indicators Market Research Report 2025
The global market for Biological Indicators was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 610 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-03-28
Pages: 86
USD 2900.00
(Single User License)
Biological Indicators- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological Indicators was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 101
USD 3950.00
(Single User License)
Global Biological Indicators Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Published Date: 2024-04-17
Pages: 154
USD 5600.00
(Single User License)
Global Biological Indicators Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Biological Indicators market size was US$ 433 million in 2025 and is forecast to reach a readjusted size of US$ 643 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 93
USD 4250.00 (Single User License)Global Biological Indicators Market Research Report 2026
The global Biological Indicators market was valued at US$ 433 million in 2025 and is anticipated to reach US$ 643 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)Biological Indicators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biological Indicators was estimated to be worth US$ 433 million in 2025 and is projected to reach US$ 643 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
USD 3950.00 (Single User License)Biological Indicators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological Indicators was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-11-03
Pages: 115
USD 3950.00 (Single User License)Global Biological Indicators Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Biological Indicators market is projected to grow from US$ 411 million in 2024 to US$ 610 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 136
USD 4900.00 (Single User License)Global Biological Indicators Market Insights, Forecast to 2031
The global Biological Indicators market is projected to grow from US$ 433 million in 2025 to US$ 610 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.
Published: 2025-03-28
Pages: 143
USD 4900.00 (Single User License)Global Biological Indicators Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Biological Indicators was estimated to be worth US$ 411 million and is forecast to reach approximately US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 132
USD 5900.00 (Single User License)Global Biological Indicators Market Research Report 2025
The global market for Biological Indicators was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 610 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-03-28
Pages: 86
USD 2900.00 (Single User License)Biological Indicators- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biological Indicators was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 101
USD 3950.00 (Single User License)Global Biological Indicators Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Published: 2024-04-17
Pages: 154
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now